Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safe, effective and cost-effective oxygen saturation targets for children and adolescents with respiratory distress
2023-504817-56-00Phase 4Completed
- Sponsor
- Spaarne Gasthuis
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxygen in bronchiolitis, episodic viral wheeze (EVW), airway hyperresponsiveness (AHR) and 2 more (2 arms), sponsored by Spaarne Gasthuis. Primary endpoint: Time from admission to meeting all discharge criteria. Started Jun 2023; status: completed.
02
Drugs
oxygen
03
Conditions
bronchiolitisepisodic viral wheeze (EVW)airway hyperresponsiveness (AHR)pulmonary infectionrespiratory distress syndrome (RDS)
Beyond the preview
Go deeper on 2023-504817-56-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504817-56-00.